Regulation of Interleukin-5 Receptor Signaling
IL-5 受体信号传导的调节
基本信息
- 批准号:6650360
- 负责人:
- 金额:$ 10.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-01 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:biological signal transduction colony stimulating factor cytokine receptors eosinophil eosinophilia gene mutation genetically modified animals hypersensitivity interleukin 3 interleukin 5 laboratory mouse phosphorylation proteasome protein degradation protein kinase serine site directed mutagenesis tyrosine ubiquitin
项目摘要
DESCRIPTION (provided by applicant): Dr. Martinez-Moczygemba is a postdoctoral
fellow whose research interest is to identify the molecular events mediating
interleukin-5 (IL-5)-induced signal termination. Understanding these
mechanisms should provide novel targets for the modulation of IL-5-mediated
inflammatory responses such as allergic inflammation and asthma. The Research
Scholar Development Award (K22) will aid Dr. Martinez-Moczygemba to accomplish
her research goals as well as to attain a tenure-track assistant professor
appointment. IL-5 specifically promotes the differentiation and survival of
eosinophils and is critical to the pathobiology of eosinophilic inflammation
in allergic disorders and asthma. IL-5 initiates its cellular effects by
binding to a heterodimeric IL-5 receptor leading to the activation of the
JAK!STAT, Ras/MAPK, and the PI3 kinase signaling pathways. The goal of this
proposal is to delineate the molecular events that initiate, mediate, and
modulate termination of IL-5 signal transduction. Aim I. Elucidate the
molecular events that initiate proteasome termination of IL-5-induced signal
transduction. We will determine if tyrosine or serine phosphorylation of betac
is required for its proteasomal degradation by using specific inhibitors of
these kinases, as well as making site-directed mutants of these beta-c
phosphorylation sites. We will also determine if beta-c ubiquitination is
necessary for its proteasomal degradation. Aim 2. Investigate the molecular
mechanisms that mediate endocytosis and lysosomal degradation of the full
length and truncated IL-5R following IL-5 stimulation. Potential endocytic
consensus sequences in the cytoplasmic domains of beta-c and IL-5R-alpha will
be evaluated for their role in ligand-induced endocytosis of the full-length
receptors by targeted deletions and by site-directed mutagenesis. Aim 3.
Determine if other shared cytokine signaling receptor chains are
proteasomally-regulated. Other shared signaling receptor chains such as gamma-
c / IL-4R-alpha will be analyzed for their susceptibility to degradation by
proteasomes following ligand stimulation. Aim 4. Demonstrate the physiologic
consequence of cytokine-induced heterotypic desensitization of beta-c
receptors in vivo. GM-CSF and IL-3 over-expressing transgenic mice will be
evaluated for their ability to develop eosinophilia following treatment with
high doses of IL-5. In addition, eosinophils from IL-5 transgenic mice will be
isolated and analyzed for their ability to be further stimulated by GM-CSF or
IL-3 in vitro.
描述(由申请人提供):Martinez-Moczygemba 博士是一名博士后
研究员,其研究兴趣是确定介导的分子事件
白细胞介素 5 (IL-5) 诱导的信号终止。了解这些
机制应为 IL-5 介导的调节提供新的靶点
炎症反应,例如过敏性炎症和哮喘。研究
学者发展奖(K22)将帮助 Martinez-Moczygemba 博士完成
她的研究目标以及获得终身教授助理教授
预约。 IL-5特异性促进细胞的分化和存活
嗜酸性粒细胞,对嗜酸性粒细胞炎症的病理学至关重要
过敏性疾病和哮喘。 IL-5 通过以下方式启动其细胞作用:
与异二聚体 IL-5 受体结合,导致激活
JAK!STAT、Ras/MAPK 和 PI3 激酶信号通路。此举的目标
提议是描述启动、介导和调节的分子事件
调节 IL-5 信号转导的终止。目标 I. 阐明
启动蛋白酶体终止 IL-5 诱导信号的分子事件
转导。我们将确定 betac 的酪氨酸或丝氨酸是否磷酸化
其蛋白酶体降解需要使用特定的抑制剂
这些激酶,以及制作这些 β-c 的定点突变体
磷酸化位点。我们还将确定 beta-c 泛素化是否是
其蛋白酶体降解所必需的。目标 2. 研究分子
介导全细胞内吞作用和溶酶体降解的机制
IL-5刺激后的长度和截短的IL-5R。潜在的内吞作用
β-c 和 IL-5R-α 细胞质结构域中的共有序列将
评估它们在配体诱导的全长内吞作用中的作用
通过定向删除和定点诱变来识别受体。目标3。
确定其他共享的细胞因子信号传导受体链是否
蛋白酶体调节。其他共享信号受体链,例如γ-
c / IL-4R-alpha 将通过以下方式分析其降解敏感性
配体刺激后的蛋白酶体。目标 4. 展示生理学
细胞因子诱导的β-c异型脱敏的结果
体内受体。 GM-CSF 和 IL-3 过表达转基因小鼠将
评估他们在治疗后出现嗜酸性粒细胞增多的能力
高剂量的IL-5。此外,来自IL-5转基因小鼠的嗜酸性粒细胞将被
分离并分析其被 GM-CSF 进一步刺激的能力或
IL-3 体外。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAGARITA MARTINEZ-MOCZYGEMBA其他文献
MAGARITA MARTINEZ-MOCZYGEMBA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MAGARITA MARTINEZ-MOCZYGEMBA', 18)}}的其他基金
Proteasome Regulation of Interleukin-5 Receptor Endocyt*
Interleukin-5 受体内吞细胞的蛋白酶体调节*
- 批准号:
6948288 - 财政年份:2004
- 资助金额:
$ 10.8万 - 项目类别:
Proteasome Regulation of Interleukin-5 Receptor Endocytosis
Interleukin-5 受体胞吞作用的蛋白酶体调节
- 批准号:
7195020 - 财政年份:2004
- 资助金额:
$ 10.8万 - 项目类别:
Proteasome Regulation of Interleukin-5 Receptor Endocytosis
Interleukin-5 受体胞吞作用的蛋白酶体调节
- 批准号:
7731884 - 财政年份:2004
- 资助金额:
$ 10.8万 - 项目类别:
Proteasome Regulation of IL-5 Receptor Endocytosis
IL-5 受体胞吞作用的蛋白酶体调节
- 批准号:
6861635 - 财政年份:2004
- 资助金额:
$ 10.8万 - 项目类别:
Proteasome Regulation of Interleukin-5 Receptor Endocyt*
Interleukin-5 受体内吞细胞的蛋白酶体调节*
- 批准号:
7020698 - 财政年份:2004
- 资助金额:
$ 10.8万 - 项目类别:
相似海外基金
Different Roles for Colony Stimulating Factor 1 Isoforms in Anabolic Therapy for Low Bone Mass
集落刺激因子 1 同工型在低骨量合成代谢治疗中的不同作用
- 批准号:
10585240 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
SBIR Phase II: Development Of An Orally Administered Gene Therapy For Granulocyte Colony-Stimulating Factor
SBIR II 期:开发粒细胞集落刺激因子口服基因疗法
- 批准号:
2133290 - 财政年份:2022
- 资助金额:
$ 10.8万 - 项目类别:
Cooperative Agreement
Blockade of colony stimulating factor 1 receptor to reduce inflammatory nerve injury
阻断集落刺激因子 1 受体以减少炎症神经损伤
- 批准号:
10195632 - 财政年份:2021
- 资助金额:
$ 10.8万 - 项目类别:
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation
F-18 标记的 PET 示踪剂,用于神经炎症中巨噬细胞集落刺激因子 1 受体 (CSF1R) 的成像
- 批准号:
9912886 - 财政年份:2020
- 资助金额:
$ 10.8万 - 项目类别:
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation
F-18 标记的 PET 示踪剂,用于神经炎症中巨噬细胞集落刺激因子 1 受体 (CSF1R) 的成像
- 批准号:
10260389 - 财政年份:2020
- 资助金额:
$ 10.8万 - 项目类别:
Expanded Clinical Trial of Granulocyte Colony-Stimulating Factor (G-CSF) to Treat Hot Flush and Other Vasomotor Symptoms in Women with Naturally-Occurring and Surgically-Induced Menopause
粒细胞集落刺激因子 (G-CSF) 治疗自然发生和手术引起的更年期女性潮热和其他血管舒缩症状的扩大临床试验
- 批准号:
9907820 - 财政年份:2020
- 资助金额:
$ 10.8万 - 项目类别:
Granulocyte macrophage colony stimulating factor regulation of macrophage functions
粒细胞巨噬细胞集落刺激因子调节巨噬细胞功能
- 批准号:
551190-2020 - 财政年份:2020
- 资助金额:
$ 10.8万 - 项目类别:
University Undergraduate Student Research Awards
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation
F-18 标记的 PET 示踪剂,用于神经炎症中巨噬细胞集落刺激因子 1 受体 (CSF1R) 的成像
- 批准号:
10390394 - 财政年份:2020
- 资助金额:
$ 10.8万 - 项目类别:
Role of colony stimulating factor 1 receptor (CSF1R) in graft vascular disease
集落刺激因子 1 受体 (CSF1R) 在移植血管疾病中的作用
- 批准号:
9755232 - 财政年份:2018
- 资助金额:
$ 10.8万 - 项目类别:
Role of colony stimulating factor 1 receptor (CSF1R) in graft vascular disease
集落刺激因子 1 受体 (CSF1R) 在移植血管疾病中的作用
- 批准号:
9611843 - 财政年份:2018
- 资助金额:
$ 10.8万 - 项目类别: